Rates of cardiovascular disease following smoking cessation in patients with HIV infection: results from the D:A:D study*
Open Access
- 20 January 2011
- journal article
- research article
- Published by Wiley in HIV Medicine
- Vol. 12 (7), 412-421
- https://doi.org/10.1111/j.1468-1293.2010.00901.x
Abstract
Objectives The aim of the study was to estimate the rates of cardiovascular disease (CVD) events after stopping smoking in patients with HIV infection. Methods Patients who reported smoking status and no previous CVD prior to enrolment in the Data Collection on Adverse Events of Anti‐HIV Drugs (D:A:D) study were included in this study. Smoking status is collected at each visit as current smoker (yes/no) and ever smoker (yes/no). Time since stopping smoking was calculated for persons who had reported current smoking during follow‐up and no current smoking subsequently. Endpoints were: myocardial infarction (MI); coronary heart disease (CHD: MI plus invasive coronary artery procedure or death from other CHD); CVD (CHD plus carotid artery endarterectomy or stroke); and all‐cause mortality. Event rates were calculated for never, previous and current smokers, and smokers who stopped during follow‐up. Incidence rate ratios (IRRs) were determined using Poisson regression adjusted for age, sex, cohort, calendar year, family history of CVD, diabetes, lipids, blood pressure and antiretroviral treatment. Results A total of 27 136 patients had smoking status reported, with totals of 432, 600, 746 and 1902 MI, CHD, CVD and mortality events, respectively. The adjusted IRR of CVD in patients who stopped smoking during follow‐up decreased from 2.32 within the first year of stopping to 1.49 after >3 years compared with those who never smoked. Similar trends were observed for the MI and CHD endpoints. Reductions in risk were less pronounced for all‐cause mortality. Conclusion The risk of CVD events in HIV‐positive patients decreased with increasing time since stopping smoking. Smoking cessation efforts should be a priority in the management of HIV‐positive patients.Keywords
This publication has 34 references indexed in Scilit:
- Risk of Myocardial Infarction in Patients with HIV Infection Exposed to Specific Individual Antiretroviral Drugs from the 3 Major Drug Classes: The Data Collection on Adverse Events of Anti‐HIV Drugs (D:A:D) StudyThe Journal of Infectious Diseases, 2010
- Bacterial Pneumonia among HIV-Infected Patients: Decreased Risk After Tobacco Smoking Cessation. ANRS CO3 Aquitaine Cohort, 2000–2007PLOS ONE, 2010
- Motivation and patch treatment for HIV+ smokers: a randomized controlled trialAddiction, 2009
- HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignanciesAIDS, 2008
- Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaborationThe Lancet, 2008
- Decreased Awareness of Current Smoking Among Health Care Providers of HIV-positive Compared to HIV-negative VeteransJournal of General Internal Medicine, 2007
- Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDSInternational Journal of Epidemiology, 2004
- Mortality in relation to smoking: 50 years' observations on male British doctorsBMJ, 2004
- Cigarette Smoking, Bacterial Pneumonia, and Other Clinical Outcomes in HIV-1 InfectionJAIDS Journal of Acquired Immune Deficiency Syndromes, 1996
- The Risk of Myocardial Infarction after Quitting Smoking in Men under 55 Years of AgeNew England Journal of Medicine, 1985